AI-generated summary
The authors randomized temporomandibular joint pain patients to active low-level laser therapy (810 nm diode, 0.1 W) or placebo over eight sessions and assessed pain, mouth opening and clicking. Pain fell within both groups, but there was no significant difference between active laser and placebo, and the authors conclude laser was not better than placebo for reducing pain during function.
- Who or what was studied
- Patients with temporomandibular joint pain, randomly assigned to two groups of 20
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The abstract reports a small sample of 40 patients split into two groups of 20 and suggests the approach may need more tailored application given the multifactorial disorder.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
- Power
- 0.1 W
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Placebo-controlled. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.